Rare EU Fast-Track Nod For Sanofi Genzyme's Olipudase Alfa
Product Is One Of Few To Secure Accelerated Assessment In Recent Months
Only three planned marketing authorization applications are known to have been granted accelerated assessment status by the European Medicines Agency between July and October this year.
